Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,044,316 | -894,040 | -24,982 | -362,686 | N/A |
| Depreciation Amortization | 291,040 | 226,941 | 61,153 | 571,887 | N/A |
| Income taxes - deferred | -53,762 | -12,308 | -6,240 | -26,115 | N/A |
| Accounts receivable | 111,500 | 141,875 | 111,613 | -94,550 | N/A |
| Accounts payable and accrued liabilities | -10,680 | 145,324 | 157,668 | 65,187 | N/A |
| Other Working Capital | -144,045 | 21,322 | -67,332 | -15,194 | N/A |
| Other Operating Activity | 680,287 | 373,430 | -266,946 | 22,966 | 3,297,133 |
| Operating Cash Flow | $-169,976 | $2,544 | $-35,066 | $161,495 | $3,297,133 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124,454 | -88,572 | -38,813 | -107,439 | -845,794 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 47,182 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -409,969 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 1,026,536 |
| Purchase Sale Intangibles | -14,217 | -10,635 | -8,977 | -17,297 | N/A |
| Other Investing Activity | -16,127 | -12,545 | -9,387 | -9,094 | 20,606 |
| Investing Cash Flow | $-140,581 | $-101,117 | $-48,200 | $-116,533 | $-161,438 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 776,984 | N/A | N/A |
| Debt Issued | 2,442,484 | 1,630,184 | N/A | 2,101,600 | 1,242,251 |
| Debt Repayment | -2,171,784 | -1,495,184 | N/A | -2,345,797 | -3,136,724 |
| Common Stock Repurchased | -6,656 | -6,656 | -1,503 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -739,763 |
| Other Financing Activity | 41,530 | -3,867 | -682,703 | -23,406 | -55,231 |
| Financing Cash Flow | $305,574 | $124,477 | $92,778 | $-267,603 | $-2,689,467 |
| Exchange Rate Effect | 1,767 | 1,801 | 542 | -901 | -13,699 |
| Beginning Cash Position | 49,382 | 49,382 | 49,382 | 272,924 | 2,574,159 |
| End Cash Position | 46,166 | 77,087 | 59,436 | 49,382 | 3,006,688 |
| Net Cash Flow | $-3,216 | $27,705 | $10,054 | $-223,542 | $432,529 |
| Free Cash Flow | |||||
| Operating Cash Flow | -169,976 | 2,544 | -35,066 | 161,495 | 3,297,133 |
| Capital Expenditure | -177,823 | -123,576 | -55,697 | -210,865 | -912,427 |
| Free Cash Flow | -347,799 | -121,032 | -90,763 | -49,370 | 2,384,706 |